Table of contents
Volume 93, Issue 2
Published online 19 July 2005 (173-269)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor
Minireview
Potential for improvement of docetaxel-based chemotherapy: a pharmacological review FREE
F K Engels, A Sparreboom, R A A Mathot and J Verweij
Br J Cancer 93: 173-177; advance online publication, July 12, 2005; doi:10.1038/sj.bjc.6602698
Clinical Studies
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial FREE
G M Mead, M H Cullen, R Huddart, P Harper, G J S Rustin, P A Cook, S P Stenning and M Mason on behalf of the MRC Testicular Tumour Working Party
Br J Cancer 93: 178-184; advance online publication, July 5, 2005; doi:10.1038/sj.bjc.6602682
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC) FREE
F Di Costanzo, P Carlini, L Doni, B Massidda, R Mattioli, A Iop, E Barletta, L Moscetti, F Recchia, P Tralongo and S Gasperoni
Br J Cancer 93: 185-189; advance online publication, June 28, 2005; doi:10.1038/sj.bjc.6602640
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer FREE
F Lordick, S Lorenzen, J Stollfuss, U Vehling-Kaiser, F Kullmann, M Hentrich, R Zumschlinge, H Dietzfelbinger, J Thoedtmann, M Hennig, T Seroneit, R Bredenkamp, J Duyster and C Peschel
Br J Cancer 93: 190-194; advance online publication, July 12, 2005; doi:10.1038/sj.bjc.6602697
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer FREE
A H Ko, J Hwang, A P Venook, J L Abbruzzese, E K Bergsland and M A Tempero
Br J Cancer 93: 195-199; advance online publication, July 5, 2005; doi:10.1038/sj.bjc.6602687
Fertility, gonadal and sexual function in survivors of testicular cancer FREE
R A Huddart, A Norman, C Moynihan, A Horwich, C Parker, E Nicholls and D P Dearnaley
Br J Cancer 93: 200-207; advance online publication, July 5, 2005; doi:10.1038/sj.bjc.6602677
Translational Therapeutics
Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development FREE
D R Camidge, M N Pemberton, J W Growcott, D Johnstone, P J Laud, J R Foster, K J Randall and A M Hughes
Br J Cancer 93: 208-215; advance online publication, July 5, 2005; doi:10.1038/sj.bjc.6602686
Combined effects of GSTP1 and MRP1 in melanoma drug resistance FREE
P Depeille, P Cuq, I Passagne, A Evrard and L Vian
Br J Cancer 93: 216-223; advance online publication, July 5, 2005; doi:10.1038/sj.bjc.6602681
Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma FREE
A M Shannon, D J Bouchier-Hayes, C M Condron and D Toomey
Br J Cancer 93: 224-232; advance online publication, July 5, 2005; doi:10.1038/sj.bjc.6602685
Molecular Diagnostics
Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells FREE
J S Wey, M J Gray, F Fan, A Belcheva, M F McCarty, O Stoeltzing, R Somcio, W Liu, D B Evans, M Klagsbrun, G E Gallick and L M Ellis
Br J Cancer 93: 233-241; advance online publication, June 14, 2005; doi:10.1038/sj.bjc.6602663
p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression FREE
E Piaton, J Faÿnel, A Ruffion, J G Lopez, P Perrin and M Devonec
Br J Cancer 93: 242-247; advance online publication, July 5, 2005; doi:10.1038/sj.bjc.6602684
T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia FREE
J C Steele, C H Mann, S Rookes, T Rollason, D Murphy, M G Freeth, P H Gallimore and S Roberts
Br J Cancer 93: 248-259; advance online publication, June 28, 2005; doi:10.1038/sj.bjc.6602679
Genetics and Genomics
Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia FREE
J H Olsen, J M D Hahnemann, A-L Børresen-Dale, S Tretli, R Kleinerman, R Sankila, L Hammarström, T E Robsahm, H Kääriäinen, A Bregård, K Brøndum-Nielsen, J Yuen and M Tucker
Br J Cancer 93: 260-265; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602658
Letters to the Editor
Multiple myeloma and fever of unknown origin: a need for therapy FREE
N Mumoli and M Cei
Br J Cancer 93: 266; advance online publication, July 12, 2005; doi:10.1038/sj.bjc.6602693
Evolving therapeutic role of bisphosphonates in multiple myeloma FREE
A U Ural and F Avcu
Br J Cancer 93: 267-268; advance online publication, July 12, 2005; doi:10.1038/sj.bjc.6602694
Reply to letters on review 'Evolving treatment strategies for myeloma' FREE
G J Morgan and F E Davies
Br J Cancer 93: 269; advance online publication, July 12, 2005; doi:10.1038/sj.bjc.6602695
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
